SCHEMBL18599488

SCHEMBL18599488

N#Cc1cccc(-c2nc(-c3ccnc4c3ccn4CO)no2)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRM5 P41594 6/20 0.51
CHRNB2 P17787 1/20 0.49
CHRNA5 P30532 1/20 0.49
CHRNA4 P43681 1/20 0.49
S1PR1 P21453 4/20 0.40
ELANE P08246 1/20 0.38
CLK4 Q9HAZ1 6/20 0.38
CPT2 P23786 1/20 0.38
CPT1A P50416 1/20 0.38
CYP1A2 P05177 4/20 0.38
CYP3A4 P08684 4/20 0.38
CYP2D6 P10635 4/20 0.38
CYP2C19 P33261 4/20 0.38
MAPK1 P28482 2/20 0.38
ALDH1A1 P00352 2/20 0.38
ALOX15 P16050 1/20 0.38
HSD17B10 Q99714 1/20 0.38
LMNA P02545 2/20 0.37
USP30 Q70CQ3 1/20 0.37
MEN1 O00255 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL99105 0.84 GRM5 (0.45) GRM5CHRNB2CHRNA5CHRNA4S1PR1
SCHEMBL26654199 0.84 GRM5 (0.45) GRM5CHRNB2CHRNA5CHRNA4S1PR1
SCHEMBL18638700 0.82 GRM5 (0.43) GRM5CHRNB2CHRNA5CHRNA4S1PR1
SCHEMBL100554 0.74 S1PR1 (0.58) GRM5CHRNB2CHRNA5CHRNA4S1PR1
SCHEMBL16691082 0.73 GRM5 (0.53) GRM5
Trifluoroacetic Acid SCHEMBL4096255 0.69 S1PR3 (0.49) GRM5CHRNB2CHRNA5CHRNA4S1PR1
SCHEMBL1544854 0.69 NOTUM (0.60) GRM5CHRNB2CHRNA5CHRNA4CLK4
SCHEMBL4192743 0.68 GRM5 (1.00) GRM5CHRNB2CHRNA5CHRNA4MAPK1
SCHEMBL1423089 0.68 CHRNB2 (0.78) GRM5CHRNB2CHRNA5CHRNA4CLK4
SCHEMBL30065433 0.67 CHRNB2 (1.00) GRM5CHRNB2CHRNA5CHRNA4S1PR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3184526-A1 PYRROLO[2,3-D]PYRIMIDINE DERIVATIVES AS JANUS KINASE INHIBITOR Incyte Holdings Corporation (US) 2017-06-28 EP disclosed
EP-2348023-B9 Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitors INCYTE HOLDINGS CORP (US) 2017-03-08 EP disclosed